ACE I/D polymorphism in Indian patients with hypertrophic cardiomyopathy and dilated cardiomyopathy

Taranjit Singh Rai1, Perundurai Subramaniam Dhandapany, Tarunveer Singh Ahluwalia

  • 1Department of Experimental Medicine and Biotechnology, Post Graduate Institute of Medical Education and Research, Chandigarh 160012, India.

Insights

The angiotensin converting enzyme (ACE) D allele is linked to a higher risk of hypertrophic cardiomyopathy (HCM) and dilated cardiomyopathy (DCM). This genetic variant influences disease phenotypes in patients with these heart conditions.

Area of Science:

  • Cardiovascular Genetics
  • Molecular Cardiology
  • Genetic Epidemiology

Background:

  • Cardiomyopathies, including hypertrophic cardiomyopathy (HCM), dilated cardiomyopathy (DCM), and restrictive cardiomyopathy (RCM), represent significant cardiovascular diseases.
  • The angiotensin converting enzyme (ACE) insertion/deletion (I/D) polymorphism is a potential genetic risk factor for various cardiovascular conditions.

Purpose of the Study:

  • To investigate the association between the ACE I/D polymorphism and the risk of developing HCM, DCM, and RCM.
  • To explore the influence of ACE I/D genotypes on clinical phenotypes and disease severity in cardiomyopathy patients.

Main Methods:

  • Case-control study including 174 cardiomyopathy patients (118 HCM, 51 DCM, 5 RCM) and 164 matched controls.
  • ACE I/D genotyping performed using polymerase chain reaction (PCR).
  • Statistical analysis adjusted for age, sex, body mass index (BMI), and smoking habit.

Main Results:

  • The ACE DD genotype and 'D' allele were significantly more prevalent in cardiomyopathy patients compared to controls, indicating an increased risk (DD: OR 2.11; 'D' allele: OR 1.91).
  • Male patients exhibited a higher frequency of cardiomyopathy compared to female patients (P < 0.05).
  • In DCM patients, the ID genotype was associated with a significantly reduced left ventricular ejection fraction (LVEF) at enrollment (26.50 +/- 8.04%, P = 0.04).

Conclusions:

  • The 'D' allele of the ACE I/D polymorphism is a significant genetic factor associated with an increased risk and specific phenotypes of HCM and DCM.
  • ACE I/D polymorphism may play a role in the pathogenesis and clinical presentation of these cardiomyopathies.
Abstract

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...